• Projects
  • VMS - Vaginal Microbiome Screening

VMS - Vaginal Microbiome Screening | Commercialisation and scale up of a Vaginal Microbiome Screening service with a menstrual tampon collection device and a digital layer to provide diagnosis, disease risk evaluation and aftercare.

Summary
VMS is a home-based gynaecological test kit, using a menstrual tampon for sample collection. VMS will improve the accuracy and convenience with which STI, vaginal infections and HPV screening is undertaken.
Daye has patented the proprietary protocol for DNA extraction from a tampon for PCR analysis, testing for 16 different factors at a time. VMS can be used to detect vaginal dysbiosis, HPV and STIs, like chlamydia, gonorrhea and trichomoniasis. Vaginal microbiome screening with VMS will unlock invaluable insights into our customers’ vaginal health. There’s a direct correlation between vaginal microbiome health and the likelihood of contracting an STI, developing a gynecological cancer, experiencing fertility and pregnancy challenges, as well as susceptibility to recurrent vaginal and urethral infections.
Post screen, VMS will offer comprehensive aftercare, including prescriptions, doctor consultations, booking in-person visits, and vaginal microbiome enhancement plan with probiotics
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/190192897
Start date: 01-07-2023
End date: 30-06-2025
Total budget - Public funding: 3 794 918,75 Euro - 2 499 999,00 Euro
Cordis data

Original description

VMS is a home-based gynaecological test kit, using a menstrual tampon for sample collection. VMS will improve the accuracy and convenience with which STI, vaginal infections and HPV screening is undertaken.
Daye has patented the proprietary protocol for DNA extraction from a tampon for PCR analysis, testing for 16 different factors at a time. VMS can be used to detect vaginal dysbiosis, HPV and STIs, like chlamydia, gonorrhea and trichomoniasis. Vaginal microbiome screening with VMS will unlock invaluable insights into our customers’ vaginal health. There’s a direct correlation between vaginal microbiome health and the likelihood of contracting an STI, developing a gynecological cancer, experiencing fertility and pregnancy challenges, as well as susceptibility to recurrent vaginal and urethral infections.
Post screen, VMS will offer comprehensive aftercare, including prescriptions, doctor consultations, booking in-person visits, and vaginal microbiome enhancement plan with probiotics

Status

SIGNED

Call topic

HORIZON-EIC-2023-ACCELERATOROPEN-01

Update Date

12-03-2024
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
EU-Programme-Call
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.0 Cross-cutting call topics
HORIZON-EIC-2023-ACCELERATOR-01
HORIZON-EIC-2023-ACCELERATOROPEN-01 EIC Accelerator Open 2023